Comparison of clinicopathological features and outcome of breast cancer in BRCA-mutation carriers, in patients with a family history without BRCA-mutation and in patients with sporadic disease

被引：0
|
作者：
Becourt, Stephanie [1 ]
Doucet, Ludovic [2 ]
Cohen-Haguenauer, Odile [1 ]
Ledoux, Florence [1 ]
Nguyen, Olivia [1 ]
Campedel, Luca [3 ]
Giacchetti, Sylvie [1 ]
Cuvier, Caroline [1 ]
Espie, Marc [1 ]
Teixeira, Luis [1 ]
机构：
[1] St Louis Hosp, Paris, France
[2] ICO Rene Gauducheau, St Herblain, France
[3] La Pitie Salpetriere Univ Hosp, Paris, France
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P5-03-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-03-06
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Outcome of patients with breast cancer and a germline BRCA mutation in a prospective cohort.
    Arun, Banu
    Barrera, Angelica Gutierrez
    Layman, Rachel M.
    Gruschkus, Stephen K.
    Bedrosian, Isabelle
    Albarracin, Constance T.
    Barcenas, Carlos Hernando
    Valero, Vicente
    Litton, Jennifer Keating
    Tripathy, Debu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] The Prognostic Relevance of Poly (ADP-Ribose) Polymerase Expression in Ovarian Cancer Tissue of Wild Type and BRCA-Mutation Carrier Patients
    Molnar, Szabolcs
    Vida, Beata
    Beke, Livia
    Mehes, Gabor
    Poka, Robert
    DIAGNOSTICS, 2021, 11 (01)
  • [43] The importance of a family history of breast cancer in predicting the presence of a BRCA mutation
    Foulkes, WD
    Brunet, JS
    Warner, E
    Goodwin, PJ
    Meschino, W
    Narod, SA
    Goss, PE
    Glendon, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (06) : 1776 - 1779
  • [44] Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer
    Han, S-H
    Lee, K-R
    Lee, D-G
    Kim, B-Y
    Lee, K-E
    Chung, W-S
    CLINICAL GENETICS, 2006, 70 (06) : 496 - 501
  • [45] Tislelizumab plus AG regimen for long-term CR in 2 patients with metastatic BRCA-mutation pancreatic cancer: A case report
    Gao, Feng
    Xu, Xue
    Chen, Chunhong
    Lv, Lili
    MEDICINE, 2024, 103 (52)
  • [46] Risk of breast cancer (BC) after BRCA-mutation associated ovarian cancer (BRCA-OC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
    Jhaveri, K. L.
    Patil, S.
    Khasraw, M.
    Bhatia, J.
    Stadler, Z. K.
    Kauff, N. D.
    Hudis, C.
    Offit, K.
    Robson, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] A computer model to simulate family history of breast/ovarian cancer in BRCA1 mutation carriers
    Bajdik, CD
    Raboud, JM
    Schechter, MT
    McGillivray, BC
    Gallagher, RP
    MATHEMATICAL BIOSCIENCES, 2001, 171 (01) : 99 - 111
  • [48] Analysis of Surgical Choice of Patients with Actionable Non-BRCA Carriers in Comparison to BRCA Gene Mutation Carriers
    Miller-Ocuin, Jennifer
    Chiba, Akiko
    Levine, Edward
    Howard-McNatt, Marissa
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S594 - S594
  • [49] Screening of the Portuguese BRCA2 Founder Mutation in Breast Cancer Patients Unselected for Family History
    Opiniao, A.
    Fragoso, S.
    Lourenco, P.
    Sousa, P.
    Braga, S.
    Luis, A.
    Machado, P.
    Rodrigues, P.
    Vicente, H.
    Oliveira, J.
    Bruges-Armas, J.
    Vaz, F.
    CANCER RESEARCH, 2009, 69 (24) : 665S - 666S
  • [50] Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history
    Peter Choon Eng Kang
    Sze Yee Phuah
    Kavitta Sivanandan
    In Nee Kang
    Eswary Thirthagiri
    Jian Jun Liu
    Norhashimah Hassan
    Sook-Yee Yoon
    Meow Keong Thong
    Miao Hui
    Mikael Hartman
    Cheng Har Yip
    Nur Aishah Mohd Taib
    Soo Hwang Teo
    Breast Cancer Research and Treatment, 2014, 144 : 635 - 642
12345